Form 4: Merck SVP Dalton Smart Reports Acquisition of Shares Following Performance Share Unit Payout
SEC Form 4 Filing
Dalton Smart, SVP Fin. Global Controller at Merck & Co., Inc., reports acquiring 2,586 shares of common stock at $97.94 per share following the satisfaction of performance criteria for performance share units.
Summary
- Dalton Smart, a Senior Vice President and Global Controller at Merck & Co., Inc., filed a Form 4 with the SEC.
- The form reports a transaction that occurred on January 27, 2025, where Mr. Smart acquired 2,586 shares of Merck common stock at a price of $97.94 per share.
- This acquisition was due to the satisfaction of performance criteria for performance share units granted on March 31, 2022.
- The performance shares were paid out at 169 percent of target awards and include dividends accrued over the three-year performance period ending December 31, 2024.
- Following the transaction, Mr. Smart directly owns 7,014.286 shares of Merck common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the vesting of performance share units at 169% suggests the company performed well. Insider ownership is generally viewed as a positive sign.
Positives
- The vesting of performance share units at 169% of target suggests strong performance by Merck over the performance period.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Comparison to Industry Standards
- Performance-based equity compensation is a common practice among large publicly traded companies like Merck, including peers such as Johnson & Johnson (JNJ) and Pfizer (PFE).
- The specific vesting percentage of 169% would need to be compared against industry benchmarks and Merck's historical performance to assess whether it is above or below average.
- Companies often use a mix of financial and operational metrics to determine performance share payouts, and the details of these metrics are usually disclosed in the company's proxy statements.
Stakeholder Impact
- Shareholders may view the vesting of performance share units at above target as a positive indicator of company performance.
- Employees who also hold performance-based compensation may be encouraged by the company's ability to achieve its goals.
Key Dates
| Date | Description |
|---|---|
| 2022-03-31 | Date of grant for the performance share units. |
| 2024-12-31 | End of the three-year performance period for the share units. |
| 2025-01-27 | Date of the transaction where shares were acquired. |
| 2025-01-29 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.